iPSC-based in vitro model of Parkinson's disease caused by OPA1 mutations

被引：0
|
作者：
Iannielli, A. [1 ]
Folladori, L. [1 ]
Cancellieri, C. [1 ]
Morabito, G. [1 ]
Massimino, L. [1 ]
Indrigo, M. [1 ]
Segnali, A. [3 ]
Maresca, A. [4 ,5 ]
Caporali, L. [4 ,5 ]
Carelli, V. [4 ,5 ]
Tiranti, V. [3 ]
Broccoli, V. [1 ,2 ]
机构：
[1] Ist Sci San Raffaele, Div Neurosci, Stem Cell & Neurogenesis Unit, Milan, Italy
[2] CNR, Natl Res Council, Inst Neurosci, Milan, Italy
[3] IRCCS Fdn Neurol Inst C Besta, Div Mol Neurogenet, Milan, Italy
[4] Bellaria Hosp, IRCCS Inst Neurol Sci Bologna, Bologna, Italy
[5] Univ Bologna, Dept Biomed & Neuromotor Sci, Neurol Unit, Bologna, Italy
来源：
HUMAN GENE THERAPY | 2016年 / 27卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P097
引用
收藏
页码：A75 / A75
页数：1
相关论文
共 50 条
  • [21] Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson's Disease (vol 23, pg 123, 2018)
    Sommer, Annika
    Marxreiter, Franz
    Krach, Florian
    Fadler, Tanja
    Grosch, Janina
    Maroni, Michele
    Graef, Daniela
    Eberhardt, Esther
    Riemenschneider, Markus J.
    Yeo, Gene W.
    Kohl, Zacharias
    Xiang, Wei
    Gage, Fred H.
    Winkler, Jurgen
    Prots, Iryna
    Winner, Beate
    CELL STEM CELL, 2019, 24 (06) : 1006 - 1006
  • [22] Transcriptome Analysis of Severe Congenital Neutropenia Associated Leukemia with Different Types of RUNX1 Mutations in an iPSC-Based Model
    Dannenmann, Benjamin
    Oswald, Benedikt
    Ritter, Malte U.
    Nasri, Masoud
    Bernhard, Regine
    Zeidler, Cornelia
    Welte, Karl
    Skokowa, Julia
    Klimiankou, Maksim
    BLOOD, 2020, 136
  • [23] Tau phosphorylation and OPA1 proteolysis are unrelated events: Implications for Alzheimer's Disease
    Alavi, Marcel, V
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2021, 1868 (12):
  • [24] IPSC-Derived Astrocytes Contribute to In Vitro Modeling of Parkinson's Disease Caused by the GBA1 N370S Mutation
    Yarkova, Elena S.
    Grigor'eva, Elena V.
    Medvedev, Sergey P.
    Pavlova, Sophia V.
    Zakian, Suren M.
    Malakhova, Anastasia A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [25] An iPSC-Based Model System of Classic MAP2K1+Melorheostosis
    Allbritton-King, Jules
    Navid, Fatemah
    Maity, Jyoti
    Bhattacharyya, Timothy
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 291 - 291
  • [26] A scalable human iPSC-based neuromuscular disease model on suspended biobased elastomer nanofiber scaffolds
    Cheesbrough, Aimee
    Harley, Peter
    Riccio, Federica
    Wu, Lei
    Song, Wenhui
    Lieberam, Ivo
    BIOFABRICATION, 2023, 15 (04)
  • [27] In Vitro Model of Parkinson's Disease
    不详
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2010, 38 (04): : 263 - 263
  • [28] iPSC-based model of Vogt-Koyanagi-Harada disease for phenotype recapitulation and drug screening
    Li, Wanqian
    Tan, Jun
    He, Siyuan
    Yue, Yingying
    Liu, Huan
    Li, Ruonan
    Wang, Xiaotang
    Wang, Guoqing
    Fan, Wei
    Zhao, Chenyang
    Zhou, Qian
    Yang, Peizeng
    Hou, Shengping
    CLINICAL IMMUNOLOGY, 2023, 246
  • [29] Diagnostic delay in Parkinson's disease caused by PRKN mutations
    Ruiz-Lopez, Marta
    Freitas, Maria Eliza
    Oliveira, Lais M.
    Munhoz, Renato P.
    Fox, Susan H.
    Rohani, Mohammad
    Rogaeva, Ekaterina
    Lang, Anthony E.
    Fasano, Alfonso
    PARKINSONISM & RELATED DISORDERS, 2019, 63 : 217 - 220
  • [30] Activation of cryptic splice sites is a frequent splicing defect mechanism caused by mutations in exon and intron sequences of the OPA1 gene
    Simone Schimpf
    Simone Schaich
    Bernd Wissinger
    Human Genetics, 2006, 118 : 767 - 771
12345